Squarepoint Ops LLC Celldex Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 71,176 shares of CLDX stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,176

Previous 74,010 3.83%

Holding current value

$1.42 Million

Previous $2.51 Million 28.48%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $66,060 - $91,821	-2,834 Reduced 3.83%	71,176 $1.8 Million
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $2.85 Million - $3.97 Million	-88,997 Reduced 54.6%	74,010 $2.51 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $1.79 Million - $2.32 Million	54,517 Added 50.25%	163,007 $6.03 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $3.2 Million - $4.72 Million	90,936 Added 518.04%	108,490 $4.55 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $131,929 - $237,192	5,835 Added 49.79%	17,554 $696,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $354,968 - $448,603	11,719 New	11,719 $397,000
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $179,403 - $293,064	6,458 New	6,458 $287,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $1.61 Million - $2.92 Million	78,345 New	78,345 $2.11 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $569,494 - $810,149	-20,604 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $378,386 - $596,743	10,605 Added 106.06%	20,604 $796,000
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $289,471 - $559,844	9,999 New	9,999 $540,000
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $931,846 - $1.59 Million	-44,995 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $1.13 Million - $2.09 Million	-69,769 Reduced 60.79%	44,995 $927,000
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $1.22 Million - $1.85 Million	81,382 Added 243.79%	114,764 $2.01 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $322,136 - $507,072	33,382 New	33,382 $495,000
Q2 2019 Aug 14, 2019	SELL	$2.43 - $5.09 $29,475 - $61,741	-12,130 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $41,848 - $125,545	12,130 New	12,130 $60,000

Others Institutions Holding CLDX

# of Institutions

196

Shares Held

60.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $935M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Celldex Therapeutics, Inc. Transaction History